Yahua Group Plans to Repurchase Shares with an Investment of 100 Million to 200 Million Yuan
Shanghai Securities News (reported by Luo Min) — YaHua Group announced that the company plans to use its own funds to repurchase part of its publicly traded shares. This share repurchase aims to maintain the company's value and protect shareholders' rights. The repurchased shares will be sold through centralized bidding within 12 months after the announcement of the repurchase results and share changes, and the sale will be completed within three years after the announcement. The total amount of repurchase funds will be no less than 100 million yuan and no more than 200 million yuan, with a proposed repurchase price not exceeding 12 yuan per share.
Newdot Software: Plans to Repurchase Shares Worth 100 Million to 200 Million Yuan
Shanghai Securities News (Reporter Ziyuan Kong) New Point Software announced that the company plans to repurchase shares through centralized bidding. The repurchase amount will be no less than 100 million yuan and no more than 200 million yuan; the repurchase price will not exceed 36 yuan per share.
Palm Co., Ltd. Plans to Repurchase Shares with an Investment of 50 Million to 100 Million Yuan
Shanghai Securities News (Reporter Luo Min) — Palm Co., Ltd. announced that the company plans to repurchase its shares through centralized bidding using its own or raised funds to maintain the company's value and protect shareholders' rights. The total amount of funds for this repurchase will be no less than 50 million yuan and no more than 100 million yuan, with a repurchase price not exceeding 3.48 yuan per share.
General Healthy: Signing of "Smart Pharmacy" Strategic Cooperation Agreement
Shanghai Securities News (Reporter Ziyuan Kong) — General Healthy announced that the company has formally signed the "Strategic Cooperation Agreement on 'Smart Pharmacies'" with another company. Both parties agree that the development prospects of the "Smart Pharmacy" model, which applies AI and robotics to further enhance pharmaceutical logistics through digital and intelligent technologies for unmanned terminals, are highly promising. General Healthy commits to giving priority to the production of digital and intelligent equipment required for the cooperation project, providing 7x24-hour operation and maintenance support, and actively developing new products tailored to the project. The other company promises to provide technical support and operational support for the project.
QingSong Co., Ltd. Plans to Repurchase Shares with an Investment of 50 Million to 100 Million Yuan
Shanghai Securities News (Reporter Luo Min) —— QingSong Co., Ltd. announced that the company plans to repurchase some of its shares through centralized bidding using its own funds for the purpose of implementing an employee stock ownership plan or equity incentive plan. The total amount of funds for this share repurchase will be no less than 50 million yuan and no more than 100 million yuan, with a repurchase price not exceeding 6 yuan per share.
Hyatech Performance Express: Net Profit Increased by 349.66% Year-on-Year in 2023
China Securities News (Reporter Ziyuan Kong) Hyatech released its earnings快报. In 2023, the company achieved a total operating revenue of 543.7232 million yuan, an increase of 49.99% year-on-year; net profit attributable to the parent company's owners was 90.212 million yuan, an increase of 349.66% year-on-year; net profit attributable to the parent company's owners after deducting non-recurring gains and losses was 83.3476 million yuan, an increase of 448.31% year-on-year.
Pharmaresources (Shanghai) Co., Ltd. Plans to Repurchase Shares with an Investment of 50 Million to 100 Million Yuan
Shanghai Securities News (Reporter Luo Min) — Pharmaresources (Shanghai) Co., Ltd. announced that the company plans to use its own funds to repurchase its issued Renminbi ordinary shares (A-shares) through centralized bidding. The repurchased shares will be used for subsequent equity incentives or employee stock ownership plans. The total amount of funds for this share repurchase will be no less than 50 million yuan and no more than 100 million yuan, with a repurchase price not exceeding 45.00 yuan per share.
China Chemistry: Controlling Shareholder Intends to Increase Company Shares by 200 Million to 400 Million Yuan
China Securities Journal News (Reporter Ziyuan Kong) China National Chemical Engineering announced that Guohua Investment Group Co., Ltd., a concerted actor of the company's controlling shareholder China National Chemical Engineering, plans to increase its holdings of the company’s A-share within 12 months from the date of this announcement. The total amount of the increase will be no less than 200 million yuan and no more than 400 million yuan. This increase plan does not set a price range, and the funding source is Guohua Company's own funds and self-raised funds.
Bio-join Pharma and Peptech Bio Sign "Technical Service (Entrustment) Contract"
Shanghai Securities News (Reporter Luo Min) — Boji Pharmaceutical announced that the company signed a "Technical Service (Entrustment) Contract" with Jiangsu Nuotai Aosainuo Biopharmaceutical Co., Ltd. on February 19, 2024. The total contract amount is 107.65 million yuan (including tax). According to the contract, Nuotai Biopharma entrusts Boji Pharmaceutical to provide clinical research services for "Semaglutide Injection."
Xiangyuan Cultural Tourism: Revenue from scenic area operations during the 2024 Spring Festival holiday increased by 37.81% year-on-year
Shanghai Securities News (reported by Kong Ziyuan) — Xiangyuan Cultural Tourism announced that during the Spring Festival holiday in 2024 (February 10 to February 17), its scenic areas (including comprehensive operations at Anhui Qiyun Mountain Scenic Area, Huangshan Xiangyuan Yungu Resort Hotel, Zhangjiajie Huanglong Cave boat tours and value-added services, Zhangjiajie Bailong Elevator, Fenghuang Ancient City Tuojiang River boat tours, and comprehensive operations at Ya'an Bifeng Gorge Scenic Area) received 487,100 visitors, representing a 40.30% increase compared to the Spring Festival holiday in 2023 and a 71.23% increase compared to the Spring Festival holiday in 2019. Revenue reached 31.1052 million yuan, marking a 37.81% increase compared to the Spring Festival holiday in 2023 and a 68.64% increase compared to the Spring Festival holiday in 2019.